Although this case did not take place in New Jersey, it provides a unique example of the potentially life-changing harm that can take place following a misdiagnosis of breast cancer. Normally, plaintiffs file medical malpractice lawsuits after doctors have failed to...
Breslin & Breslin, P.A.
New Jersey pedestrians have greater crash risk on older highways
Pedestrians who walk along older state highways are at a greater risk of being fatally struck by a motor vehicle, according to a new report. This increased pedestrian accident rate is present even on streets with sidewalks, indicating that New Jersey transportation...
FDA device director supports closing approval loophole (2)
Earlier this week, we talked about the loophole in the U.S. Food and Drug Administration's 510(k) medical device approval process which reportedly allowed for the approval of a vaginal mesh product manufactured by New Jersey-based Johnson & Johnson. Recently,...
FDA device director supports closing approval loophole (1)
Last month, we wrote about federal legislators' efforts to close the loophole in the U.S. Food and Drug Administration's medical device approval process. Now, it appears that a top official with the device division of the FDA agrees that such a change should be made....
Accidents caused by angry drivers at issue in proposed NJ law
In 2005, a 16-year-old New Jersey teenager was paralyzed from the chest down in a single-car crash when the vehicle in which she was a passenger slammed into a telephone pole. A police investigation later revealed that road rage was responsible for the car accident....
Johnson & Johnson CEO to step down in April
After a string of product recalls and products liability lawsuits, the chief executive officer of Johnson & Johnson is reportedly stepping down from his position later this spring. Although the New Jersey company's revenue has doubled in the past decade, the many...
DePuy sold hip replacements overseas after FDA rejection (2)
Earlier this week, we began an in-depth look into the convoluted process by which Johnson & Johnson and its unit DePuy Orthopaedics sought FDA approval for its articular surface replacement devices, or ASRs. Initially, the FDA rejected the medical product, stating...
DePuy sold hip replacements overseas after FDA rejection (1)
New documents have revealed that DePuy Orthopaedics, a unit of New Jersey-based Johnson & Johnson, continued to sell faulty hip replacement joints internationally after they were rejected for sale by the U.S. Food and Drug Administration. At the same time, DePuy...
Jury awards damages for missed breast cancer diagnosis
When a 50-year-old woman discovered a marble-sized lump in her breast, she went to her doctor for a mammogram, hoping and praying that she did not have breast cancer. She thought her prayers were granted when her doctor concluded that there was "no evidence of...
Faulty hip replacements can cause long-term injuries
Recently, the faulty metal-on-metal hip replacement joints manufactured by DePuy Orthopaedics, a unit of New Jersey-based Johnson & Johnson, have become the subject of scrutiny and debate after causing pain and injury to thousands of patients. According to a few...
